Trial Outcomes & Findings for Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects (NCT NCT01145066)

NCT ID: NCT01145066

Last Updated: 2019-07-18

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

80 participants

Primary outcome timeframe

baseline

Results posted on

2019-07-18

Participant Flow

80 participants signed consent, only 71 were randomized to an arm/group

Participant milestones

Participant milestones
Measure
Borage and Echium Oil Combination
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
corn oil: contains 4.5 g/day linoleic acid
Overall Study
STARTED
26
20
25
Overall Study
COMPLETED
22
16
21
Overall Study
NOT COMPLETED
4
4
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Borage and Echium Oil Combination
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
corn oil: contains 4.5 g/day linoleic acid
Overall Study
To resume NSAIDs
2
2
1
Overall Study
Non-related surgery
0
0
1
Overall Study
Withdrawal by Subject
0
0
2
Overall Study
To start new med
1
0
0
Overall Study
problems swallowing capsule
1
0
0
Overall Study
Abdominal discomfort
0
1
0
Overall Study
Low platelet count
0
1
0

Baseline Characteristics

Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Total
n=59 Participants
Total of all reporting groups
Age, Continuous
57.4 years
STANDARD_DEVIATION 7.8 • n=93 Participants
56.2 years
STANDARD_DEVIATION 8.7 • n=4 Participants
59.9 years
STANDARD_DEVIATION 9.8 • n=27 Participants
57.96 years
STANDARD_DEVIATION 8.8 • n=483 Participants
Sex: Female, Male
Female
10 Participants
n=93 Participants
10 Participants
n=4 Participants
15 Participants
n=27 Participants
35 Participants
n=483 Participants
Sex: Female, Male
Male
12 Participants
n=93 Participants
6 Participants
n=4 Participants
6 Participants
n=27 Participants
24 Participants
n=483 Participants

PRIMARY outcome

Timeframe: baseline

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Fasting Insulin
15.4 μIU/mL
Standard Deviation 2.0
19.1 μIU/mL
Standard Deviation 4.5
20.2 μIU/mL
Standard Deviation 3.2

PRIMARY outcome

Timeframe: 4 weeks and 8 weeks combined

Fasting insulin data at 4 and 8 weeks was averaged.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Fasting Insulin
17.7 μIU/mL
Standard Deviation 2.6
24.6 μIU/mL
Standard Deviation 6.8
20.6 μIU/mL
Standard Deviation 3.3

PRIMARY outcome

Timeframe: baseline

Changes in high sensitive C-reactive protein (hsCRP) were assessed.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
hsCRP
3.03 mg/L
Standard Deviation .85
6.08 mg/L
Standard Deviation 3.19
2.36 mg/L
Standard Deviation .57

PRIMARY outcome

Timeframe: 4 weeks and 8 weeks combined

Changes in high sensitive C-reactive protein (hsCRP) were assessed and data at 4 and 8 weeks was averaged..

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
hsCRP
3.06 mg/L
Standard Deviation .86
3.59 mg/L
Standard Deviation 1.03
3.72 mg/L
Standard Deviation 1.00

PRIMARY outcome

Timeframe: baseline

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Leptin
33.3 ng/mL
Standard Deviation 6.2
45.1 ng/mL
Standard Deviation 11.0
53.5 ng/mL
Standard Deviation 6.8

PRIMARY outcome

Timeframe: 4 weeks and 8 weeks combined

Data at 4 and 8 weeks was averaged.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Leptin
33.9 ng/mL
Standard Deviation 7.4
40.6 ng/mL
Standard Deviation 7.2
44.2 ng/mL
Standard Deviation 5.3

SECONDARY outcome

Timeframe: baseline

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Serum Fatty Acids
C14:1
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
Cl4:0
.69 percentage of total fatty acids
Standard Deviation .08
.72 percentage of total fatty acids
Standard Deviation .07
.70 percentage of total fatty acids
Standard Deviation .07
Serum Fatty Acids
C15:0
.13 percentage of total fatty acids
Standard Deviation .02
.16 percentage of total fatty acids
Standard Deviation .02
.15 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C15:1
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C16:0
20.64 percentage of total fatty acids
Standard Deviation .41
21.65 percentage of total fatty acids
Standard Deviation .47
21.19 percentage of total fatty acids
Standard Deviation .40
Serum Fatty Acids
C16:1 n-7
1.58 percentage of total fatty acids
Standard Deviation .08
1.92 percentage of total fatty acids
Standard Deviation .24
1.68 percentage of total fatty acids
Standard Deviation .13
Serum Fatty Acids
C17:1
.10 percentage of total fatty acids
Standard Deviation .02
.13 percentage of total fatty acids
Standard Deviation .03
.08 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C18:0
7.23 percentage of total fatty acids
Standard Deviation .14
7.00 percentage of total fatty acids
Standard Deviation .25
7.47 percentage of total fatty acids
Standard Deviation .09
Serum Fatty Acids
C18:1
.12 percentage of total fatty acids
Standard Deviation .07
.17 percentage of total fatty acids
Standard Deviation .06
.21 percentage of total fatty acids
Standard Deviation .06
Serum Fatty Acids
C18:1 n-9
19.6 percentage of total fatty acids
Standard Deviation .44
21.92 percentage of total fatty acids
Standard Deviation .98
20.63 percentage of total fatty acids
Standard Deviation .96
Serum Fatty Acids
C18:1 n-11
1.5 percentage of total fatty acids
Standard Deviation .07
1.84 percentage of total fatty acids
Standard Deviation .06
1.60 percentage of total fatty acids
Standard Deviation .06
Serum Fatty Acids
C18:2 n-6 [LA]
32.67 percentage of total fatty acids
Standard Deviation .98
29.71 percentage of total fatty acids
Standard Deviation 1.28
31.99 percentage of total fatty acids
Standard Deviation 1.26
Serum Fatty Acids
C18:3 n-6 [GLA]
.59 percentage of total fatty acids
Standard Deviation .04
.55 percentage of total fatty acids
Standard Deviation .05
.53 percentage of total fatty acids
Standard Deviation .03
Serum Fatty Acids
C18:3 n-3 [ALA]
.80 percentage of total fatty acids
Standard Deviation .05
.77 percentage of total fatty acids
Standard Deviation .09
.73 percentage of total fatty acids
Standard Deviation .06
Serum Fatty Acids
C18:4 n-3 [SDA]
.01 percentage of total fatty acids
Standard Deviation .01
.01 percentage of total fatty acids
Standard Deviation .01
.03 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C20:0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
.01 percentage of total fatty acids
Standard Deviation .01
Serum Fatty Acids
C20:1 n-9
.04 percentage of total fatty acids
Standard Deviation .01
.10 percentage of total fatty acids
Standard Deviation .02
.08 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C20:2 n-6
.32 percentage of total fatty acids
Standard Deviation .01
.33 percentage of total fatty acids
Standard Deviation .02
.30 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C20:3 n-6 [DGLA]
1.51 percentage of total fatty acids
Standard Deviation .08
1.43 percentage of total fatty acids
Standard Deviation .09
1.68 percentage of total fatty acids
Standard Deviation .08
Serum Fatty Acids
C20:4 n-6 [AA]
9.12 percentage of total fatty acids
Standard Deviation .40
8.68 percentage of total fatty acids
Standard Deviation .40
8.17 percentage of total fatty acids
Standard Deviation .56
Serum Fatty Acids
C20:5 n-3 [EPA]
.573 percentage of total fatty acids
Standard Deviation .05
.56 percentage of total fatty acids
Standard Deviation .07
.48 percentage of total fatty acids
Standard Deviation .04
Serum Fatty Acids
C22:0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C22:1 n-9
.15 percentage of total fatty acids
Standard Deviation .06
0 percentage of total fatty acids
Standard Deviation 0
.05 percentage of total fatty acids
Standard Deviation .04
Serum Fatty Acids
C22:2 n-6
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C22:5 n-3 [DPA]
.55 percentage of total fatty acids
Standard Deviation .02
.59 percentage of total fatty acids
Standard Deviation .03
.54 percentage of total fatty acids
Standard Deviation .03
Serum Fatty Acids
C24:0
.02 percentage of total fatty acids
Standard Deviation .02
0 percentage of total fatty acids
Standard Deviation 0
.02 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C22:6 n-3 [DHA]
1.63 percentage of total fatty acids
Standard Deviation .10
1.73 percentage of total fatty acids
Standard Deviation .016
1.71 percentage of total fatty acids
Standard Deviation .12
Serum Fatty Acids
C24:1 n-9
.01 percentage of total fatty acids
Standard Deviation .01
.04 percentage of total fatty acids
Standard Deviation .02
.03 percentage of total fatty acids
Standard Deviation .02

SECONDARY outcome

Timeframe: 4 weeks and 8 weeks combined

Data at 4 and 8 weeks was averaged.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Serum Fatty Acids
C14:1
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C16:0
20.49 percentage of total fatty acids
Standard Deviation .37
20.76 percentage of total fatty acids
Standard Deviation .39
20.75 percentage of total fatty acids
Standard Deviation .37
Serum Fatty Acids
C16:1 n-7
1.39 percentage of total fatty acids
Standard Deviation .08
1.55 percentage of total fatty acids
Standard Deviation .14
1.57 percentage of total fatty acids
Standard Deviation .13
Serum Fatty Acids
C17:1
.05 percentage of total fatty acids
Standard Deviation .02
.06 percentage of total fatty acids
Standard Deviation .02
.04 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C24:0
.01 percentage of total fatty acids
Standard Deviation .01
.01 percentage of total fatty acids
Standard Deviation .01
.02 percentage of total fatty acids
Standard Deviation .01
Serum Fatty Acids
C22:6 n-3 [DHA]
1.63 percentage of total fatty acids
Standard Deviation .10
3.58 percentage of total fatty acids
Standard Deviation .11
1.60 percentage of total fatty acids
Standard Deviation .11
Serum Fatty Acids
Cl4:0
.66 percentage of total fatty acids
Standard Deviation .04
.62 percentage of total fatty acids
Standard Deviation .06
.66 percentage of total fatty acids
Standard Deviation .05
Serum Fatty Acids
C15:0
.14 percentage of total fatty acids
Standard Deviation .02
.14 percentage of total fatty acids
Standard Deviation .02
.14 percentage of total fatty acids
Standard Deviation .02
Serum Fatty Acids
C15:1
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C18:0
7.55 percentage of total fatty acids
Standard Deviation .16
7.39 percentage of total fatty acids
Standard Deviation .27
7.62 percentage of total fatty acids
Standard Deviation .12
Serum Fatty Acids
C18:1
.13 percentage of total fatty acids
Standard Deviation .05
.25 percentage of total fatty acids
Standard Deviation .06
.25 percentage of total fatty acids
Standard Deviation .05
Serum Fatty Acids
C18:1 n-9
19.60 percentage of total fatty acids
Standard Deviation .44
20.24 percentage of total fatty acids
Standard Deviation .52
20.30 percentage of total fatty acids
Standard Deviation .61
Serum Fatty Acids
C18:1 n-11
1.44 percentage of total fatty acids
Standard Deviation .05
1.56 percentage of total fatty acids
Standard Deviation .06
1.51 percentage of total fatty acids
Standard Deviation .06
Serum Fatty Acids
C18:2 n-6 [LA]
30.97 percentage of total fatty acids
Standard Deviation .80
29.94 percentage of total fatty acids
Standard Deviation 1.14
33.11 percentage of total fatty acids
Standard Deviation .93
Serum Fatty Acids
C18:3 n-6 [GLA]
1.2 percentage of total fatty acids
Standard Deviation .08
.45 percentage of total fatty acids
Standard Deviation .05
.52 percentage of total fatty acids
Standard Deviation .03
Serum Fatty Acids
C18:3 n-3 [ALA]
1.05 percentage of total fatty acids
Standard Deviation .05
.83 percentage of total fatty acids
Standard Deviation .06
.71 percentage of total fatty acids
Standard Deviation .05
Serum Fatty Acids
C18:4 n-3 [SDA]
.08 percentage of total fatty acids
Standard Deviation .01
.02 percentage of total fatty acids
Standard Deviation .01
.01 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C20:0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
.01 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C20:1 n-9
.04 percentage of total fatty acids
Standard Deviation .01
.03 percentage of total fatty acids
Standard Deviation .01
.05 percentage of total fatty acids
Standard Deviation .01
Serum Fatty Acids
C20:2 n-6
.24 percentage of total fatty acids
Standard Deviation .01
.23 percentage of total fatty acids
Standard Deviation .18
.31 percentage of total fatty acids
Standard Deviation .01
Serum Fatty Acids
C20:3 n-6 [DGLA]
1.97 percentage of total fatty acids
Standard Deviation .09
1.45 percentage of total fatty acids
Standard Deviation .07
1.61 percentage of total fatty acids
Standard Deviation .05
Serum Fatty Acids
C20:4 n-6 [AA]
9.16 percentage of total fatty acids
Standard Deviation .34
7.31 percentage of total fatty acids
Standard Deviation .36
8.11 percentage of total fatty acids
Standard Deviation .46
Serum Fatty Acids
C20:5 n-3 [EPA]
.89 percentage of total fatty acids
Standard Deviation .08
2.79 percentage of total fatty acids
Standard Deviation .18
.46 percentage of total fatty acids
Standard Deviation .05
Serum Fatty Acids
C22:0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C22:1 n-9
.15 percentage of total fatty acids
Standard Deviation .06
.19 percentage of total fatty acids
Standard Deviation .11
.11 percentage of total fatty acids
Standard Deviation .04
Serum Fatty Acids
C22:2 n-6
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
Serum Fatty Acids
C22:5 n-3 [DPA]
.55 percentage of total fatty acids
Standard Deviation .02
.89 percentage of total fatty acids
Standard Deviation .03
.51 percentage of total fatty acids
Standard Deviation .03
Serum Fatty Acids
C24:1 n-9
0 percentage of total fatty acids
Standard Deviation 0
0 percentage of total fatty acids
Standard Deviation 0
.01 percentage of total fatty acids
Standard Deviation .01

SECONDARY outcome

Timeframe: baseline

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 weeks and 8 weeks combined

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: baseline

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Fasting Glucose
125.9 mg/dL
Standard Deviation 7.3
133.5 mg/dL
Standard Deviation 16.7
130.0 mg/dL
Standard Deviation 9.8

SECONDARY outcome

Timeframe: 4 weeks and 8 weeks combined

Data at 4 and 8 weeks was averaged.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Fasting Glucose
125.9 mg/dL
Standard Deviation 1.09
128.7 mg/dL
Standard Deviation 11.1
130.7 mg/dL
Standard Deviation 11.2

SECONDARY outcome

Timeframe: baseline

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Hemoglobin Levels
6.81 mg/dL
Standard Deviation .30
7.42 mg/dL
Standard Deviation .33
7.15 mg/dL
Standard Deviation .34

SECONDARY outcome

Timeframe: 4 weeks and 8 weeks combined

Data at 4 and 8 weeks was averaged.

Outcome measures

Outcome measures
Measure
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=16 Participants
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
Hemoglobin Levels
6.90 mg/dL
Standard Deviation .27
7.20 mg/dL
Standard Deviation .32
7.07 mg/dL
Standard Deviation .35

SECONDARY outcome

Timeframe: 4 weeks

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: baseline

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 weeks

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: baseline

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 weeks

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: baseline

Population: No data collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 weeks

Population: No data collected

Outcome measures

Outcome data not reported

Adverse Events

Borage and Echium Oil Combination

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Fish Oil

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Corn Oil

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Borage and Echium Oil Combination
n=26 participants at risk
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
Fish Oil
n=20 participants at risk
Croda 18:12 fish oil fish oil: 1.6g/day EPA and 1.08g/day DHA
Corn Oil
n=25 participants at risk
corn oil: contains 4.5 g/day linoleic acid
Immune system disorders
Sick/virus
11.5%
3/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
15.0%
3/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
12.0%
3/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
Gastrointestinal disorders
GI Upset
0.00%
0/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
5.0%
1/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
0.00%
0/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
Nervous system disorders
Headache
3.8%
1/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
0.00%
0/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
0.00%
0/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
Metabolism and nutrition disorders
Weak
0.00%
0/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
5.0%
1/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
4.0%
1/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.

Additional Information

Dr. Michael Seeds

Wake Forest University Health Sciences

Phone: 3367169811

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place